Top

Published in:

01-03-2023 | Glioblastoma | Case report

Temozolomide

Neutropenia, thrombocytopenia and leukopenia: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Attia AM, et al. The efficacy and safety of extended adjuvant temozolomide following concurrent radio-chemotherapy among Egyptian patients with newly diagnosed glioblastoma multiforme. American Journal of Cancer Research 12: 355-370, No. 1, 30 Jan 2022. Available from: URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822288/

Title: Temozolomide
Neutropenia, thrombocytopenia and leukopenia: case report
Publication date: 01-03-2023
Publisher: Springer International Publishing
Keywords: Glioblastoma
Glioblastoma
Neutropenia
Leukopenia
Thrombocytopenia
Glioblastoma
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-35950-1

Ibrutinib

Chronic Lymphocytic Leukemia
Case report

Endostatin

Peritoneal Cancer
Case report

Elasomeran/loxoprofen

Vaccination
Case report

Octreotide

Tarry Feces
Case report

Cotrimoxazole/dexamethasone

Hair Transplant
Case report

Tozinameran

Psoriasis Guttata
Case report

Keynote series | Spotlight on managing health in obesity

Springer Medicine

Temozolomide

Neutropenia, thrombocytopenia and leukopenia: case report

Excerpt

Other articles of this Issue 1/2023

Ibrutinib

Endostatin

Elasomeran/loxoprofen

Octreotide

Cotrimoxazole/dexamethasone

Tozinameran

Springer Medicine

Excerpt

Please log in to get access to this content

Ibrutinib

Endostatin

Elasomeran/loxoprofen

Octreotide

Cotrimoxazole/dexamethasone

Tozinameran